Product Details for: Daxxify
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
For Injection
Intramuscular
50UNITS
Single-Dose Vial
351(a)
Daxxify
Rx
002
For Injection
Intramuscular
100UNITS
Single-Dose Vial
351(a)
Daxxify
Rx
Proper Name
daxibotulinumtoxinA-lanm
daxibotulinumtoxinA-lanm
BLA Number
761127
761127
Applicant
Revance Therapeutics, Inc.
Revance Therapeutics, Inc.
Original Approval Date
September 7, 2022
September 7, 2022
Date of First Licensure